Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Uterine Neoplasms × 16-fluoroestradiol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Uterine Neoplasms 1 HER2/Neu Negative 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Paclitaxel 6 Carboplatin 3 pembrolizumab 2 durvalumab 2 Radiotherapy 2 Pemetrexed 2 FANG vaccine 2 Docetaxel 2 Cisplatin 2 CP protocol 2 seribantumab 1 olaparib 1 niraparib 1 gedatolisib 1 dactolisib 1 belzutifan 1 atezolizumab 1 alovudine 1 adavosertib 1 Vitamin D 1 Trabectedin 1 Topotecan 1 TP protocol 1 Radiation 1 Proflavine 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Oxaliplatin 1 Nivolumab 1 Leuprolide 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05916196 2025-05-08

[18F]FES PET/.CT in Uterine Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡